“COVID-19 remains a significant concern, particularly for older adults and those with underlying health conditions, even as overall severity has decreased.” — Ziyad Al-Aly, MD, of Washington University in St. Louis, remarking that while severity has declined, COVID-19 still poses a particular threat for older adults and people with comorbidities.
“Physicians sometimes overlook cost-effective, equally efficacious alternatives, thereby contributing to unnecessary clinical inertia.” — John Corboy, MD, of the University of Colorado School of Medicine Anschutz, discussing a study that found off-label rituximab worked just as well as ocrelizumab (Ocrevus) in multiple sclerosis.
“Recent regulatory fluctuations reflect more disorder than a coherent trend in drug approval processes.” — Robert Steinbrook, MD, director of the Health Research Group at Public Citizen, on fluctuating FDA drug review standards following some recent reversals.
“A notable discovery revealed a gap between public distrust of health information and actual usage of social media for health-related decisions.” — Rohan Khera, MD, of Yale School of Medicine in New Haven, Connecticut, discussing findings on social media use for health information among U.S. adults.
“Early identification of tardive dyskinesia offers a promising avenue for intervention, making the condition far from hopeless.” — Tsao-Wei Liang, MD, of Thomas Jefferson University in Philadelphia, emphasizing why early recognition of tardive dyskinesia is critical.
“SGLT2 inhibitors trigger ketogenesis, a distinctive mechanism that may underlie therapeutic benefits observed in patients with certain psychiatric conditions.” — Jaime Ramos-Cejudo, PhD, of New York University Grossman School of Medicine in New York City, on the potential mechanisms for why patients with psychiatric disorders appear to derive benefit from the drugs.
“While a youth mental health crisis has persisted, recent data indicate a measurable rise in adolescent therapeutic engagement since the pandemic.” — Consuelo Cagande, MD, of Northwell Zucker Hillside Hospital in New York, on the increase in young people seeking out therapy.
“Advances in understanding pediatric head injuries from football research should inform preventive strategies in other youth sports, such as cheerleading, where recent rule modifications have demonstrably reduced injury rates.” — Audrey Litvak, MD, also of the Washington University in St. Louis, discussing research showing that rule changes were associated with fewer head injuries among cheerleaders.
